Patrick M. Bossuyt

ORCID: 0000-0003-4427-0128
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Meta-analysis and systematic reviews
  • Health Systems, Economic Evaluations, Quality of Life
  • Colorectal Cancer Screening and Detection
  • Assisted Reproductive Technology and Twin Pregnancy
  • Gastric Cancer Management and Outcomes
  • Ovarian function and disorders
  • Reliability and Agreement in Measurement
  • Statistical Methods in Clinical Trials
  • Genetic factors in colorectal cancer
  • Venous Thromboembolism Diagnosis and Management
  • Clinical practice guidelines implementation
  • Diverticular Disease and Complications
  • Reproductive Biology and Fertility
  • Healthcare cost, quality, practices
  • Ectopic Pregnancy Diagnosis and Management
  • Delphi Technique in Research
  • Pregnancy and preeclampsia studies
  • Appendicitis Diagnosis and Management
  • Reproductive Health and Technologies
  • Radiomics and Machine Learning in Medical Imaging
  • Pelvic floor disorders treatments
  • Liver Disease Diagnosis and Treatment
  • Birth, Development, and Health
  • Preterm Birth and Chorioamnionitis
  • Clinical Reasoning and Diagnostic Skills

Amsterdam University Medical Centers
2008-2025

University of Amsterdam
2016-2025

Amsterdam UMC Location University of Amsterdam
2015-2025

Public Health Service of Amsterdam
2007-2025

KU Leuven
2009-2025

Imelda Hospital
2018-2025

GGD Amsterdam
2007-2024

Phoenix Contact (United States)
2024

University of Bristol
2024

University of Chieti-Pescara
2006-2023

The Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) statement, published in 2009, was designed to help systematic reviewers transparently report why the review done, what authors did, they found. Over past decade, advances methodology terminology have necessitated an update guideline. PRISMA 2020 statement replaces 2009 includes new reporting guidance that reflects methods identify, select, appraise, synthesise studies. structure presentation of items been...

10.1136/bmj.n71 article EN cc-by BMJ 2021-03-29

The Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) statement, published in 2009, was designed to help systematic reviewers transparently report why the review done, what authors did, they found. Over past decade, advances methodology terminology have necessitated an update guideline. PRISMA 2020 statement replaces 2009 includes new reporting guidance that reflects methods identify, select, appraise, synthesise studies. structure presentation of items been...

10.1186/s13643-021-01626-4 article EN cc-by Systematic Reviews 2021-03-29

The Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) statement, published in 2009, was designed to help systematic reviewers transparently report why the review done, what authors did, they found. Over past decade, advances methodology terminology have necessitated an update guideline. PRISMA 2020 statement replaces 2009 includes new reporting guidance that reflects methods identify, select, appraise, synthesise studies. structure presentation of items been...

10.1016/j.ijsu.2021.105906 article EN cc-by International Journal of Surgery 2021-03-28

The methods and results of systematic reviews should be reported in sufficient detail to allow users assess the trustworthiness applicability review findings. Preferred Reporting Items for Systematic Meta-Analyses (PRISMA) statement was developed facilitate transparent complete reporting has been updated (to PRISMA 2020) reflect recent advances methodology terminology. Here, we present explanation elaboration paper 2020, where explain why each item is recommended, bullet points that...

10.1136/bmj.n160 article EN cc-by BMJ 2021-03-29

Background: The Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) Statement, published in 2009, was designed to help systematic reviewers transparently report why the review done, what authors did they found. Over last decade, there have been many advances methodology terminology, which necessitated an update guideline.Objectives: To develop PRISMA 2020 statement reporting reviews.Methods: We reviewed 60 documents with guidance generate suggested modifications 2009...

10.31222/osf.io/v7gm2 preprint EN 2020-09-14

In the era of evidence based medicine, with systematic reviews as its cornerstone, adequate quality assessment tools should be available. There is currently a lack systematically developed and evaluated tool for diagnostic accuracy studies. The aim this project was to combine empirical expert opinion in formal consensus method develop used assess primary studies accuracy. We conducted Delphi procedure by refining an initial list items. Members panel were experts area research. results three...

10.1186/1471-2288-3-25 article EN cc-by BMC Medical Research Methodology 2003-11-10

The Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) statement, published in 2009, was designed to help systematic reviewers transparently report why the review done, what authors did, they found. Over past decade, advances methodology terminology have necessitated an update guideline. PRISMA 2020 statement replaces 2009 includes new reporting guidance that reflects methods identify, select, appraise, synthesise studies. structure presentation of items been...

10.1016/j.jclinepi.2021.03.001 article EN cc-by Journal of Clinical Epidemiology 2021-03-29

Incomplete reporting has been identified as a major source of avoidable waste in biomedical research. Essential information is often not provided study reports, impeding the identification, critical appraisal, and replication studies. To improve quality diagnostic accuracy studies, Standards for Reporting Diagnostic Accuracy (STARD) statement was developed. Here we present STARD 2015, an updated list 30 essential items that should be included every report study. This update incorporates...

10.1136/bmj.h5527 article EN cc-by BMJ 2015-10-28

Diagnostic accuracy studies are, like other clinical studies, at risk of bias due to shortcomings in design and conduct, the results a diagnostic study may not apply patient groups settings. Readers reports need be informed about sufficient detail judge trustworthiness applicability findings. The STARD statement (Standards for Reporting Accuracy Studies) was developed improve completeness transparency studies. contains list essential items that can used as checklist, by authors, reviewers...

10.1136/bmjopen-2016-012799 article EN cc-by-nc BMJ Open 2016-11-01

The GRADE system can be used to grade the quality of evidence and strength recommendations for diagnostic tests or strategies. This article explains how patient-important outcomes are taken into account in this process

10.1136/bmj.39500.677199.ae article EN BMJ 2008-05-15

La declaración PRISMA (Preferred Reporting Items for Systematic reviews and Meta-Analyses), publicada en 2009, se diseñó para ayudar a los autores de revisiones sistemáticas documentar manera transparente el porqué la revisión, qué hicieron y encontraron. Durante última década, ha habido muchos avances metodología terminología las sistemáticas, lo que requerido una actualización esta guía. prisma 2020 sustituye 2009 e incluye nueva guía presentación publicaciones refleja métodos identificar,...

10.1016/j.recesp.2021.06.016 article ES cc-by-nc-nd Revista Española de Cardiología 2021-07-21

The quality of reporting studies diagnostic accuracy is less than optimal. Complete and accurate necessary to enable readers assess the potential for bias in study evaluate generalizability results. A group scientists editors has developed STARD (Standards Reporting Diagnostic Accuracy) statement improve accuracy. consists a checklist 25 items flow diagram that authors can use ensure all relevant information present. This explanatory document aims facilitate use, understanding, dissemination...

10.7326/0003-4819-138-1-200301070-00012-w1 article EN Annals of Internal Medicine 2003-01-07

An intravenous course of standard (unfractionated) heparin with the dose adjusted to prolong activated partial-thromboplastin time a desired length is initial in-hospital treatment for patients deep-vein thrombosis, but fixed-dose subcutaneous low-molecular-weight appears be as effective and safe. Because latter can given on an outpatient basis, we compared two treatments in symptomatic outpatients proximal-vein thrombosis no signs pulmonary embolism.

10.1056/nejm199603143341102 article EN New England Journal of Medicine 1996-03-14

More and more systematic reviews of diagnostic test accuracy studies are being published, but they can be methodologically challenging. In this paper, the authors present some recent developments in methodology for conducting studies. Restrictive electronic search filters discouraged, as is use summary quality scores. Methods meta-analysis should take into account paired nature estimates their dependence on threshold. Authors these advised to hierarchical receiver-operating characteristic or...

10.7326/0003-4819-149-12-200812160-00008 article EN Annals of Internal Medicine 2008-12-16

Abstract The quality of reporting studies diagnostic accuracy is less than optimal. Complete and accurate necessary to enable readers assess the potential for bias in study evaluate generalisability results. A group scientists editors has developed STARD (Standards Reporting Diagnostic Accuracy) statement improve accuracy. consists a checklist 25 items flow diagram that authors can use ensure all relevant information present. This explanatory document aims facilitate use, understanding...

10.1373/49.1.7 article EN Clinical Chemistry 2003-01-01

Deep-brain stimulation through an electrode implanted in the thalamus was developed as alternative to thalamotomy for treatment of drug-resistant tremor. Stimulation is thought be effective but have fewer complications. We examined effects these two procedures on functional abilities patients with tremor due Parkinson's disease, essential tremor, or multiple sclerosis.

10.1056/nejm200002173420703 article EN New England Journal of Medicine 2000-02-17
Coming Soon ...